In biopharmaceutical manufacturing, mycoplasma contamination poses serious risks to product safety and regulatory approval. Preventive screening, stringent quality control, and advanced molecular testing help mitigate risks, protecting patients and ensuring therapeutic products meet global quality standards. https://www.xelleratherapeutics.com/services/bioanalytical-testing/